Menu
Back to User profile » Prof. Dr. Moonkyoo Kong
Papers published by Prof. Dr. Moonkyoo Kong:
Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study
Kong M, Sung JY, Lee SH
OncoTargets and Therapy 2020, 13:8173-8180
Published Date: 18 August 2020
Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study
Kong M, Sung JY, Lee SH
OncoTargets and Therapy 2019, 12:8263-8273
Published Date: 9 October 2019
Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
Kong M, Lim YJ, Kim Y, Chung MJ, Min S, Shin DO, Chung W
Cancer Management and Research 2019, 11:7103-7110
Published Date: 26 July 2019
Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage Ⅲ non–small cell lung cancer
Kong M, Hong SE
OncoTargets and Therapy 2016, 9:7227-7234
Published Date: 24 November 2016
The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study
Kong M, Hwang DS, Yoon SW, Kim J
OncoTargets and Therapy 2016, 9:4533-4538
Published Date: 22 July 2016
The effect of laughter therapy on radiation dermatitis in patients with breast cancer: a single-blind prospective pilot study
Kong M, Shin SH, Lee EM, Yun EK
OncoTargets and Therapy 2014, 7:2053-2059
Published Date: 4 November 2014
Conventional fractionated helical tomotherapy for patients with small to medium hepatocellular carcinomas without portal vein tumor thrombosis
Jung J, Kong M, Hong SE
OncoTargets and Therapy 2014, 7:1769-1775
Published Date: 26 September 2014
Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity
Kong M, Hong SE, Chang SG
OncoTargets and Therapy 2014, 7:553-566
Published Date: 10 April 2014